These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 43263)

  • 21. Modulation of acetylcholine release by D1, D2 dopamine receptors in rat striatum under freely moving conditions.
    Ajima A; Yamaguchi T; Kato T
    Brain Res; 1990 Jun; 518(1-2):193-8. PubMed ID: 1975213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction of permanently uncharged dopamine analogs with the D-2 dopaminergic receptor.
    Wallace RA; Farooqui T; Wallace L; Ares J; Chang YA; Miller D; Uretsky N
    Biochem Pharmacol; 1988 May; 37(10):2077-84. PubMed ID: 2967702
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stimulation of D2-receptors in rat nucleus accumbens slices inhibits dopamine and acetylcholine release but not cyclic AMP formation.
    Stoof JC; Verheijden PF; Leysen JE
    Brain Res; 1987 Oct; 423(1-2):364-8. PubMed ID: 2823991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of bromocriptine on central dopaminergic receptors.
    Trabucchi M; Spano PF; Tonon GC; Frattola L
    Life Sci; 1976 Jul; 19(2):225-31. PubMed ID: 183071
    [No Abstract]   [Full Text] [Related]  

  • 25. Time course of the changes in striatal acetylcholine levels induced by pergolide and haloperidol after lesion of the nigrostriatal dopaminergic pathways in the rat.
    Fage D; Guerin B; Feuerstein C; Demenge P; Scatton B
    Brain Res; 1984 Sep; 310(2):379-83. PubMed ID: 6488029
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of aging on concentrations of D2-receptor-containing neurons in the rat striatum.
    Han Z; Kuyatt BL; Kochman KA; DeSouza EB; Roth GS
    Brain Res; 1989 Oct; 498(2):299-307. PubMed ID: 2529020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
    Seiler MP; Markstein R
    Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential pharmacological profile of striatal and cerebellar dopamine receptors labeled by [3H]quinpirole: identification of a discrete population of putative D3 receptors.
    Levant B; DeSouza EB
    Synapse; 1993 May; 14(1):90-5. PubMed ID: 8099762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional differences in the regulation of acetylcholine release upon D2 dopamine and N-methyl-D-aspartate receptor activation in rat nucleus accumbens and neostriatum.
    Henselmans JM; Stoof JC
    Brain Res; 1991 Dec; 566(1-2):1-7. PubMed ID: 1687661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dopamine agonist potencies of ergolines.
    Lew JY; Nakamura S; Battista AF; Goldstein M
    Commun Psychopharmacol; 1979; 3(3):179-83. PubMed ID: 115634
    [No Abstract]   [Full Text] [Related]  

  • 32. D1 and D2 dopamine receptor-regulated gene expression of striatonigral and striatopallidal neurons.
    Gerfen CR; Engber TM; Mahan LC; Susel Z; Chase TN; Monsma FJ; Sibley DR
    Science; 1990 Dec; 250(4986):1429-32. PubMed ID: 2147780
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ergoline derivative LEK-8829-induced turning behavior in rats with unilateral striatal ibotenic acid lesions: interaction with bromocriptine.
    Sprah L; Zivin M; Sket D
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1093-100. PubMed ID: 10027846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. D-1 receptor-linked mechanism modulates cholinergic neurotransmission in rat striatum.
    Consolo S; Wu CF; Fusi R
    J Pharmacol Exp Ther; 1987 Jul; 242(1):300-5. PubMed ID: 2886638
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asymmetric elevation of striatal dopamine D2 receptors in the chakragati mouse: neurobehavioral dysfunction in a transgenic insertional mutant.
    Fitzgerald LW; Miller KJ; Ratty AK; Glick SD; Teitler M; Gross KW
    Brain Res; 1992 May; 580(1-2):18-26. PubMed ID: 1354555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differential effect of systemic administration of bromocriptine and L-dopa on the release of acetylcholine from striatum of intact and 6-OHDA-treated rats.
    DeBoer P; Abercrombie ED; Heeringa M; Westerink BH
    Brain Res; 1993 Apr; 608(2):198-203. PubMed ID: 8495354
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dissociation of the striatal D-2 dopamine receptor from adenylyl cyclase following 6-hydroxydopamine-induced denervation.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):73-82. PubMed ID: 1321630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
    DeBoer P; Abercrombie ED
    J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chronic levodopa or pergolide administration induces down-regulation of dopamine receptors in denervated striatum.
    Reches A; Wagner HR; Jackson-Lewis V; Yablonskaya-Alter E; Fahn S
    Neurology; 1984 Sep; 34(9):1208-12. PubMed ID: 6540406
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guanine nucleotides reveal differential actions of ergot derivatives at D-2 receptors labelled by [3H]spiperone in striatal homogenates.
    Gundlach AL; Krstich M; Beart PM
    Brain Res; 1983 Nov; 278(1-2):155-63. PubMed ID: 6227373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.